DOI: https://doi.org/10.24026/1818-1384.4(64).2018.149974

Андрогеновий дефіцит і його вплив на стан здоров’я жінок

Л. В. Дем’яненко, Л. М. Семенюк

Анотація


В огляді проведено аналіз сучасного стану проблеми недостатності андрогенів в жіночому організмі. Обговорено питання особливостей синтезу та метаболізму андрогенів, вплив цих гормонів на репродуктивні органи жінки та на стан організму в цілому. Показано методи дослідження гомеостазу андрогенів в організмі, їх переваги та недоліки. Висвітлено стан проблеми гіпоандрогенних станів у жінок перименопаузального і постменопаузального віку, а також можливі методи корекції андрогенового дефіциту у цих категорій жінок. В цілому особливості фізіології естрогенів і прогестерону достатньо добре вивчені, в той час як для вивчення ролі андрогенів необхідні нові фундаментальні дослідження і клінічні випробування з метою всебічного вивчення ролі цих гормонів в організмі жінок різного віку. Таким чином, на сьогоднішній день не вирішені всі аспекти корекції сексуальної дисфункції жіночого населення різних вікових груп. Для вивчення ролі андрогенів при відновленні гормонального балансу жіночого організму необхідні нові фундаментальні дослідження.


Ключові слова


андрогеновий дефіцит; урогенітальні розлади

Повний текст:

PDF

Посилання


Naselennia Ukrainy. Imperatyvy demohrafichnoho starinnia [The population of Ukraine. Imperatives of demographic aging]. Kyiv: ADEF-Ukraina. 2014. 1070 p. [Ukrainian].

Kalinchenko SYu, Tyuzikov IA, Tishova YuA, Vorslov LO. [Testosterone Functions in Women. Part 1: General and Age-Specific Endocrine and Other Physiological Functions of Testosterone in Women]. Doktor.ru. Ginekologiya Endokrinologiya. 2015; (14):52-57. [Russian].

Shestakova IG, Bril YuA. [Female androgens: searching a golden median]. Status praesens. Ginekologiya, Akusherstvo, Besplodnyy Brak. 2014: (4):55-61. [Russian].

Bachmann GA, Leiblum SR. The impact of hormones on menopausal sexuality: a literature review. Menopause. 2004 Jan-Feb; 11(1):120-30.

Kalinchenko SYu, Apetov SS, Grekov EA, Tishova YuA. [Influence of female androgenic insufficiency and its correction on the disturbance of urination in women in post menopause]. Lechashchiy Vrach. 2012; (3):20-24. [Russian].

Torshin IYu, Gromova OA, Suhih GT, Galitskaya SA. Molekulyarnyie mekhanizmy didrogesterona (Dyufaston®). Polnogenomnoe issledovanie transkriptsionnykh effektov retseptorov progesterona, androgenov i estrogenov. [Molecular mechanisms of dydrogesterone (Dyufaston®). Full genome study of transcriptional effects of progesterone receptors, androgen and estrogen]. Consilium Medicum. 2009; 11(5): 9-16. [Russian].

Parker CR Jr, Slayden SM, Azziz R, Crabbe SL, Hines GA, Boots LR, Bae S. Effects of aging on adrenal function in the human: responsiveness and sensitivity of adrenal androgens and cortisol to adrenocorticotropin in premenopausal and postmenopausal women. J Clin Endocrinol Metab. 2000 Jan; 85(1):48-54.

Goncharov NP, Kolesnikova GS. Kortikosteroidy: metabolizm, mekhanizm deystviya i klinicheskoe primeneniye [Corticosteroids: metabolism, mechanism of action, and clinical application]. Moskow: Adamant. 2002. 176 p. [Russian].

Melikhova OA, Smetnik VP. [Androgen production in post-menopausal period and after oophorectomy]. Meditsinskiy Sovet. 2011; 5-6:66-78. [Russian].

Bosdou JK, Venetis CA, Kolibianakis EM, Toulis KA, Goulis DG, Zepiridis L, Tarlatzis BC. The use of androgens or androgen-modulating agents in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis. Hum Reprod Update. 2012 Mar-Apr;18(2):127-45.

Davey DA. Androgens in women before and after the menopause and post bilateral oophorectomy: clinical effects and indications for testosterone therapy. Womens Health (Lond). 2012 Jul; 8(4):437-46.

Gillies GE, McArthur S. Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines. Pharmacol Rev. 2010 Jun; 62(2):155-98.

Berman J, Almeida F, Jolin J, et al. Correlation of androgen receptors, aromatase, and 5-alpha reductase in the human vagina with menopausal status. Fertil Steril. 2003 Apr; 79(4):925-31.

Davison SL, Bell R, Donath S, et al. Androgen levels in adult females: Changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab. 2005 Jul; 90(7):3847-53.

Rosner W, Auchus RJ, Azziz R, et al. Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab. 2007 Feb; 92(2):405-13.

Vicente FB, Smith FA, Sierra R, Wang S. Measurement of serum testosterone using high-performance liquid chromatography/tandem mass spectrometry. Clin Chem Lab Med. 2006; 44(1):70-5.

Wierman ME, Basson R, Davis SR. Androgen Therapy in Women: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2006 Oct; 91(10):3697-710.

Buster JE, Kingsberg SA, Aguirre О, Brown C, Breaux JG, Buch A, Rodenberg CA, Wekselman K, Casson P. Testosterone patch for low sexual desire in surgically menopausal women: A randomized trial. Obstet Gynecol. 2005 May; 105(5 Pt 1):944-52.

Davison SL, Bell R, Donath S, Montalto JG, Davis SR. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab. 2005 Jul; 90(7):3847-53.

Davison SL, Bell R, Montalto JG, Sikaris K, Donath S, Stanczyk FZ, Davis SR. Measurement of total testosterone in women: comparison of a direct radioimmunoassay versus radioimmunoassay after organic solvent extraction and celite column partition chromatography. Fertil Steril. 2005 Dec; 84(6):1698-704.

Turna B, Apaydin E, Semerci B, Altay B, Cikili N, Nazli O. Women with low libido: correlation of decreased androgen levels with female sexual function index. Int J Impot Res. 2005 Mar-Apr; 17(2):148-53.

Guay A, Jacobson J, Munarriz R, Traish A, Talakoub L, Quirk F, Goldstein I, Spark R. Serum androgen levels in healthy premenopausal women with and without sexual dysfunction: Part B. Reduced serum androgen levels in healthy premenopausal women with complaints of sexual dysfunction. Int J Impot Res. 2004 Apr;16(2):121-9.

Dennerstein L, Koochaki P, Barton I, Graziottin A. Hypoactive sexual desire disorder in menopausal women: a survey of Western European women. J Sex Med. 2006 Mar;3(2):212-22.

Graziottin A. Prevalence and evaluation of sexual health problems — HSDD in Europe. J Sex Med. 2007 Mar; 4 Suppl 3:211-9.

Panay N, Al-Azzawi F, Bouchard C, et al. Testosterone treatment of HSDD in naturally menopausal women: the ADORE study. Climacteric. 2010 Apr; 13(2):121-31.

Nappi R. Androgens and postmenopausal sexuality. Proceedings 8th European congress of menopause, London, UK, May 16-20, 2009, p. S10.

Kalinchenko SY, Tyuzikov IA, Grekov EA, Apetov SS, Vorslov LO, Tishova Y.A. [Androgens and lower urinary tract symptoms: only male gender or unsolved problems of both sexes?] Eksperimentalnaya I Klinicheskaya Urologiya. 2013; (4):40-48. [Russian].

Hanno P, Malkowicz SB, Wein AJ, editors. Clinical Manual of Urology. Aliayev YuG, transl. M: GEOTARMedia. 2006. 543 р. [Russian]. ISBN 5-89481-213-5.

Ho MH, Bhatia NN, Bhasin S. Anabolic effects of androgens on muscles of female pelvic floor and lower urinary tract. Curr Opin Obstet Gynec. Curr Opin Obstet Gynecol. 2004 Oct; 16(5):405-9.

Panjari M, Davis SR. Vaginal DHEA to treat menopause related atrophy: a review of the evidence. Maturitas. 2011 Sep; 70(1):22-5.

Maia H, Casoy J, Valente J. Testosterone replacement therapy in climacteric: benefits beyond sexuality. Gynecol Endocrinol. 2009 Jan; 25(1):12-20.

Kokot-Kierepa M, Bartuzi A, Kulik-Rechberger B, Rechberger T. [Local estrogen therapy--clinical implications--2012 update]. Ginekol Pol. 2012 Oct;83(10):772-7. [Article in Polish].

Sylvestre C, Buckett' W. Is there a role for androgens in premenopausal women? In: Tularidi T, Gelfand M, editors. Androgens and reproductive aging. London: Taylor & Francis; 2006. р. 93-97.

Edwall L, Carlstrőm K, Jonasson AF. Markers of' collagen synthesis and degradation in urogenital tissue from women with and without stress urinary incontinence. Neurourol Urodyn. 2007; 26(3):410-5.

Edwall L, Carlstrőm K, Jonasson AF. Endocrine status and markers of collagen synthesis and degradation in serum and urogenital tissue from women with and without stress urinary incontinence. Neurourol Urodyn. 2007; 26(3):410-5.

Pessina MA, Hoyt RF Jr, Goldstein I, Traish AM. Differential effects of estradiol, progesterone, and testosterone on vaginal structural integrity. Endocrinology. 2006 Jan; 147(1):61-9.

Braunstein GD, Sundwall DA, Katz M, Shifren JL, Buster JE, Simon JA, Bachman G, Aguirre OA, Lucas JD, Rodenberg C, Buch A, Watts NB. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: randomized placebo-controlled trial. Arch Intern Med. 2005 Jul 25; 165(14):1582-9.

Nachtigall L, Casson P, Lucas J, Schofield V, Melson C, Simon JA. Safety and tolerability of testosterone patch therapy up to 4 years in surgically menopausal women receiving oral or transdermal estrogen. Gynecol Endocrinol. 2011 Jan; 27(1):39-48.

Somboonporn W, Bell RJ, Davis SR. Testosterone for peri and postmenopausal women. Cochrane Database of Systematic Reviews 2010; Issue 4: Art. No: CD004509. DOI: 10.1002/14651858. CD004509. pub2.

Stahlman J, Britto M, Fitzpatrick S, McWhirter C, Testino SA, Brennan JJ, Zumbrunnen TL. Effect of application site, clothing barrier, and application site washing on testosterone transfer with a 1.62% testosterone gel. Curr Med Res Opin. 2012 Feb; 28(2):281-90.

Sturdee DW, Pines A; International Menopause Society Writing Group, Archer DF, Baber RJ, Barlow D, Birkhäuser MH, Brincat M, Cardozo L, de Villiers TJ, Gambacciani M, Gompel AA, Henderson VW, Kluft C, Lobo RA, MacLennan AH, Marsden J, Nappi RE, Panay N, Pickar JH, Robinson D, Simon J, Sitruk-Ware RL, Stevenson JC. Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Climacteric. 2011 Jun; 14(3):302-20.

Glaser R, Dimitrakakis C. Testosterone therapy in women: Myths and misconceptions. Maturitas. 2013 Mar; 74(3):230-4.

Singh AB, Lee ML, Sinha-Hikim I, Kushnir M, Meikle W, Rockwood A, Afework S, Bhasin S. Pharmacokinetics of a testosterone gel in healthy postmenopausal women. J Clin Endocrinol Metab. 2006 Jan; 91(1):136-44.

Khaidarova FA, Nigmatova SS. [Testosterone and quality of women’s life]. Mezhdunarodnyy Endokrinologicheskiy Zhurnal. 2012; (2):137-142. [Russian].

Miller KK, Biller BM, Beauregard C, Lipman JG, Jones J, Schoenfeld D, Sherman JC, Swearingen B, Loeffler J, Klibanski A. Effects of testosterone replacement in androgen-deficient women with hypopituitarism: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab. 2006 May; 91(5):1683-90.

Chudakov B, Ben Zion IZ, Belmaker RH. Transdermal testosterone gel prn application for hypoactive sexual desire disorder in premenopausal women: a controlled pilot study of the effects on the arizona sexual experiences scale for females and sexual function questionnaire. J Sex Med. 2007 Jan;4(1):204-208.

Somboonporn W, Davis SR. Postmenopausal testosterone therapy and breast cancer risk. Maturitas. 2004 Dec 10; 49(4):267-75.

Burgess HE, Shousha S. An immunohistochemical study of the long-term effects of androgen administration on female-to-male transsexual breast: A comparison with normal female breast and male breast showing gynaecomastia. J Pathol. 1993 May; 170(1):37-43.

Dimitrakakis C, Jones RA, Liu A, Bondy CA. Breast cancer incidence in postmenopausal women using testosterone in addition to usual hormone therapy. Menopause. 2004 Sep-Oct; 11(5):531-5.

Hofling M, Carlström K, Svane G, Azavedo E, Kloosterboer H, Von Schoultz B. Different effects 'of tibolone and continuous combined estrogen plus progestogen hormone therapy on sex hormone binding globulin and free testosterone levels an association with mammographic density. Gynecol Endocrinol. 2005 Feb; 20(2):110-5.

Hofling M, Hirschberg AL, Skoog L, Tani E, Hägerström T, von Schoultz B. Testosterone inhibits estrogen/ progestogen-induced breast cell proliferation in postmenopausal women. Menopause. 2007 MarApr; 14(2):183-90.

Wierman ME, Arlt W, Basson R, Davis SR, Miller KK, Murad MH, Rosner W, Santoro N. Androgen therapy in women: a reappraisal: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2014 Oct; 99(10):3489-510.


Пристатейна бібліографія ГОСТ








Creative Commons License
Ця робота ліцензована Creative Commons Attribution 4.0 International License.

© Клінічна ендокринологія та ендокринна хірургія

ISSN: 1818-1384 (Print), e-ISSN: 2519-2582, DOI: 10.24026/1818-1384.

При копіюванні активне посилання на матеріал обов'язкове.

Flag Counter